RestrepoBI,SchlesingerLS, 2014.Impact of diabetes on the natural history of tuberculosis,Diabetes Res Clin Pract 106 191 -9
3. Jimenez CME, Cruz HLP, Garcia GL, Ferreyra-Reyes L, Delgado-Sanchez G, Bobadilla-DVM, et al. Association of diabetes and
tuberculosis: impact on treatment and post-treatment outcomes. Thorax. 2013; 68:214-20
OrmeI., 1993.Immunity to mycobacteria,Curr Opin Immunol 5 497 -502
GuiradoE,SchlesingerLS, .Modeling the Mycobacterium tuberculosis Granuloma - the Critical Battlefield in Host Immunity 6, -
RomeroMM,BasileJI,LopezB,RitaccoV,BarreraL,Sasiain MdelC, 2014.Outbreaks of Mycobacterium tuberculosis MDR strains differentially induce neutrophil respiratory burst involving lipid rafts, p38 MAPK and Syk,BMC Infect Dis 14 262 -
EruslanovEB,LyadovaIV,KondratievaTK,MajorovKB,ScheglovIV,OrlovaMO, 2005.Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice,Infect Immun 73 1744 -53
NauGJ,RichmonJFL,SchlesingerA,JenningsEG,LanderES,YoungRA, 2002.Human macrophage activation programs activated by bacterial pathogens,Proc Natl Acad Sci U S A 99 1503 -8
AndreasenAS,Pedersen-SkovsgaardT,BergRM,SvendsenKD,Feldt-RasmussenB,PedersenBK, .Type 2 diabetes mellitus is associated with impaired cytokine response and adhesion molecule expression in human endotoxemia,Intensive Care Med. -
VankayalapatiR,GargA,PorgadorA,GriffithDE,KlucarP,SafiH, 2005.Role of NK Cell-Activating Receptors and Their Ligands in the Lysis of Mononuclear Phagocytes Infected with an Intracellular Bacterium,J Immunol 175 4611 -7
NK Cells Regulate CD8+ T Cell Effector, 2003.Function in Response to an Intracellular Pathogen,J Immunol 172 130 -7
Mihret A., 2012.The role of dendritic cells in Mycobacterium tuberculosis infection,Virulence 3 654 -9
BalboaL,KviatcovskyD,SchierlohP,GarciaM,de la BarreraS,SasiainMDC, 2016.Monocyte-derived dendritic cells early exposed to Mycobacterium tuberculosis induce an enhanced T helper 17 response and transfer mycobacterial antigens,Int J Med Microbiol 306 541 -53
LyadovaIV,PanteleevAV,Biomarkers. MediatorsInflamm, 2015.Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and, 854507 -
SainiV., 2010.Molecular mechanisms of insulin resistance in type 2 diabetes mellitus,World J Diabetes 1 68 -75
DonathMY,ShoelsonSE, 2011.Type 2 diabetes as an inflammatory disease,Nat Rev Immunol 11 98 -107
PickupJC, 2004.Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes,Diabetes Care 27 813 -23
SekharRV,McKaySV,PatelSG,GuthikondaAP,ReddyVT,BalasubramanyamA, 2011.Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine,Diabetes Care 34 162 -7
2009.Normalization of obesity-associated insulin resistance through immunotherapy,Nat Med 15 921 -9
KumariP,MeenaLS, 2014.Factors affecting susceptibility to Mycobacterium tuberculosis: a close view of immunological defence mechanism,Appl Biochem Biotechnol 174 2663 -73
Kumar NathellaP,BabuS., 2017.Influence of diabetes mellitus on immunity to human tuberculosis,Immunology 152 13 -24
Alba-LoureiroTC,HirabaraSM,MendoncaJR,CuriR,Pithon-CuriTC, 2006.Diabetes causes marked changes in function and metabolism of rat neutrophils,J Endocrinol 188 295 -303
2012.Glutathione reductase facilitates host defense by sustaining phagocytic oxidative burst and promoting the development of neutrophil extracellular traps,J Immunol 188 2316 -27
2012.Glutathione deficiency in type 2 diabetes impairs cytokine responses and control of intracellular bacteria,J Clin Invest 122 2289 -300
VallerskogT,MartensGW,KornfeldH, 2010.Diabetic mice display a delayed adaptive immune response to Mycobacterium tuberculosis,J Immunol 184 6275 -82
2011.High glucose disrupts oligosaccharide recognition function via competitive inhibition: a potential mechanism for immune dysregulation in diabetes mellitus,Immunobiology 216 126 -31
GuptaS,MarathaA,SiednienkoJ,NatarajanA,GajanayakeT,HoashiS, .Analysis of inflammatory cytokine and TLR expression levels in Type 2 Diabetes with complications,Sci Rep. -
KumarNP,SridharR,BanurekhaVV,JawaharMS,NutmanTB,BabuS., 2013.Expansion of pathogen-specific T-helper 1 and T-helper 17 cells in pulmonary tuberculosis with coincident type 2 diabetes mellitus,J Infect Dis 208 739 -48
RedfordPS,BoonstraA,ReadS,PittJ,GrahamC,StavropoulosE, 2010.Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung,Eur J Immunol 40 2200 -10
Al-AttiyahRJ,MustafaAS, 2009.Mycobacterial antigen-induced T helper type 1 (Th1) and Th2 reactivity of peripheral blood mononuclear cells from diabetic and non-diabetic tuberculosis patients and Mycobacterium bovis bacilli Calmette-Guerin (BCG)-vaccinated healthy subjects,Clin Exp Immunol 158 64 -73
StalenhoefJE,AlisjahbanaB,NelwanEJ,van der Ven-JongekrijgJ,OttenhoffTH,van der MeerJW, 2008.The role of interferongamma in the increased tuberculosis risk in type 2 diabetes mellitus,Eur J Clin Microbiol Infect Dis 27 97 -103
Panee J. Monocyte, 2012.Chemoattractant Protein 1 (MCP-1) in obesity and diabetes,Cytokine 60 1 -12
EndocrinolMetab Clin North Am, 2017., 46 1061 -94
.Change in serum CXCL10 levels during anti-tuberculosis treatment depends on vitamin D status [Short Communication], -
Int J Tuberc Lung Dis, 2014., 18 466 -9
HerreraMT,GonzalezY,Hernandez-SanchezF,Fabian-San MiguelG,TorresM, .Low serum vitamin D levels in type 2 diabetes patients are associated with decreased mycobacterial activity, -
BMC InfectDis, 2017., 17 610 -
InfectImmun, 2009., 77 4690 -5
Rivas-SantiagoB,Hernandez-PandoR,CarranzaC,JuarezE,ContrerasJL,Aguilar-LeonD, 2008.Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells,Infect Immun 76 935 -41
Gonzalez-CurielI,Castaneda-DelgadoJ,Lopez-LopezN,AraujoZ,Hernandez-PandoR,Gandara-JassoB, 2011.Differential expression of antimicrobial peptides in active and latent tuberculosis and its relationship with diabetes mellitus,Hum Immunol 72 656 -62
KumarNP,MoideenK,DollaC,KumaranP,BabuS., 2017.Prediabetes is associated with the modulation of antigen-specific Th1/Tc1 and Th17/Tc17 responses in latent Mycobacterium tuberculosis infection,PLoS One 12 e0178000 -
KumarNP,BanurekhaVV,NairD,SridharR,KornfeldH,NutmanTB, 2014.Coincident pre-diabetes is associated with dysregulated cytokine responses in pulmonary tuberculosis,PLoS One 9 e112108 -
KariminiaA,SharifniaZ,ZghakhaniA,BanifazlM,EslamifarA,HazratiM, 2009.Comparison of QuantiFERON TB-G test to TST for detecting latent tuberculosis infection in a high-incidence area containing BCG-vaccinated population,J Eval Clin Prac 15 148 -51
KabeerBSA,RamanB,ThomasA,PerumalV,RajaA, 2010.Role of QuantiFERON-TB Gold, Interferon gamma, inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis,PLoS One 5 e9051 -
DenkingerCM,DhedaK,PaiM., 2011.Guidelines on interferon-gamma release assays for tuberculosis infection: concordance, discordance or confusion?,Clin Microbiol Infect 17 806 -14
ChegouNN,BlackGF,KiddM,van HeldenPD,WalzlG, 2009.Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report,BMC Pulm Med 9 21 -
KumarNP,SridharR,BanurekhaVV,JawaharMS,FayMP,NutmanTB, .Type 2 diabetes mellitus coincident with pulmonary tuberculosis is associated with heightened systemic type 1, type 17, and other proinflammatory cytokines,Ann Am Thorac Soc. -